Arieli’s hands-on, collaborative model guides portfolio companies from pre-seed to pre-IPO, helping them commercialize their innovations and providing them with the resources they need to scale.

Our joint ventures give us access to investment opportunities in their earliest stages and a front-row seat to the transformative discoveries that will become tomorrow’s cutting-edge tech.

The distinctive backgrounds of our partners give Arieli Group a unique understanding of global markets and an advantage in cross-border M&A deals. Our patient capital approach is optimized to yield long-term growth and strong financial returns for our stakeholders.